NYSE MKT LLC · CVM
-5.63% · -$0.0800 · Vol 97.6K
Live · updated 13:35:09 ET
CEL-SCI Corp

CEL-SCI Corp

Biotechnology
$1.34
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Earnings absence reason unknown · Sentiment absence reason unknown
CVM
CEL-SCI Corp
Fri Aug 21 · last completed session · daily score · 2d 19h old
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

53/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Fri Aug 21 · last completed session · daily score · 2d 19h old
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is CVM moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CVM catalysts
About CEL-SCI Corp
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
1983
Employees
44
Country
US

CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.42
Day high
$1.43
Day low
$1.34
Previous close
$1.42
52W high
$13.04
-89.72% from high
52W low
$0.9744
3% of range
Market cap
$25M
P/E
2.28×
EPS
$-3.1800
Beta
0.88
Shares out
17.6M
Volume
97.6K
0.35× rel vol
Avg volume
279.4K
VWAP
$1.39
Price history computed in-house
1W
-13.55%
1M
+13.56%
3M
-6.29%
1Y
-85.92%
YTD
-74.52%
SMA 50 $1.26 · above
SMA 200 $3.59 · below
52W position 3%

CVM overview

Veridion Score
53
Registered · 2026-08-21
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around CVM.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading CVM Form 4 filings
Public disclosures

Congress activity in CVM

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for CVM in the cached public ledger.

Federal contracts

CVM contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CVM in this window.
Lobbying spend

CVM lobbying filings, year to date.

Registered lobbying filings matched to CEL-SCI Corp.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CVM in this window.
Loading news for CVM
Analyst ratings
Sovereign unlock shows live analyst consensus for CVM.
Options
Sovereign unlock shows live options positioning for CVM.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.